All changes for the tissue central nervous system (627)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA31
carbonic anhydrase XI
Molecular
brain
Human
CA11
6.0% Decrease Gene Expression Level
DAA21
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2
Molecular
brain
Human
ATP6V1G2
7.0% Decrease Gene Expression Level
DAA19
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1
Molecular
brain
Human
ATP6V0D1
8.0% Decrease Gene Expression Level
DAA4
actin, beta
Molecular
brain
Human
ACTB
4.0% Decrease Gene Expression Level
DAA20
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A
Molecular
brain
Human
ATP6V1A
7.0% Decrease Gene Expression Level
DAA5
actin-like 6A
Molecular
brain
Human
ACTL6A
21.0% Increase Gene Expression Level
DAA2041
Altered brain mitochondrial metabolism
Physiological
brain
Human
—
—
DAA138
coiled-coil domain containing 46
Molecular
brain
Human
CCDC46
86.0% Increase Gene Expression Level
DAA748
Altered sleep parameters and patterns
Psychological
brain
Human
—
—
DAA774
Cognitive decline
Psychological
brain
Human
—
—
DAA723
Accumulation of extracellular neuritic plaques
Physiological
brain
Human
—
—
DAA753
Cognitive deficits
Psychological
brain
Human
—
—
DAA43
chimerin (chimaerin) 1
Molecular
brain
Human
CHN1
6.0% Decrease Gene Expression Level
DAA49
colony stimulating factor 2 (granulocyte-macrophage)
Molecular
brain
Human
CSF2
6.0% Increase Gene Expression Level
DAA17
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
Molecular
brain
Human
ATP5A1
17.0% Decrease Gene Expression Level
DAA11
annexin A4
Molecular
brain
Human
ANXA4
11.0% Increase Gene Expression Level
DAA18
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
Molecular
brain
Human
ATP5B
9.0% Decrease Gene Expression Level
DAA2
abl-interactor 2
Molecular
brain
Human
ABI2
18.0% Decrease Gene Expression Level
DAA8
angiomotin
Molecular
brain
Human
AMOT
10.0% Increase Gene Expression Level
DAA40
cholecystokinin B receptor
Molecular
brain
Human
CCKBR
11.0% Decrease Gene Expression Level
DAA24
B-cell CLL/lymphoma 11A (zinc finger protein)
Molecular
brain
Human
BCL11A
14.0% Decrease Gene Expression Level
DAA9
ankyrin 2, neuronal
Molecular
brain
Human
ANK2
20.0% Decrease Gene Expression Level
DAA45
Cdc2-related kinase, arginine/serine-rich
Molecular
brain
Human
CDK12
17.0% Increase Gene Expression Level
DAA47
crystallin, beta B3
Molecular
brain
Human
CRYBB3
4.0% Decrease Gene Expression Level
DAA48
crystallin, mu
Molecular
brain
Human
CRYM
12.0% Decrease Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA31 | carbonic anhydrase XI | Molecular | brain | Human | CA11 | 6.0% Decrease Gene Expression Level | |
DAA21 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | Molecular | brain | Human | ATP6V1G2 | 7.0% Decrease Gene Expression Level | |
DAA19 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 | Molecular | brain | Human | ATP6V0D1 | 8.0% Decrease Gene Expression Level | |
DAA4 | actin, beta | Molecular | brain | Human | ACTB | 4.0% Decrease Gene Expression Level | |
DAA20 | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Molecular | brain | Human | ATP6V1A | 7.0% Decrease Gene Expression Level | |
DAA5 | actin-like 6A | Molecular | brain | Human | ACTL6A | 21.0% Increase Gene Expression Level | |
DAA2041 | Altered brain mitochondrial metabolism | Physiological | brain | Human | — | — | |
DAA138 | coiled-coil domain containing 46 | Molecular | brain | Human | CCDC46 | 86.0% Increase Gene Expression Level | |
DAA748 | Altered sleep parameters and patterns | Psychological | brain | Human | — | — | |
DAA774 | Cognitive decline | Psychological | brain | Human | — | — | |
DAA723 | Accumulation of extracellular neuritic plaques | Physiological | brain | Human | — | — | |
DAA753 | Cognitive deficits | Psychological | brain | Human | — | — | |
DAA43 | chimerin (chimaerin) 1 | Molecular | brain | Human | CHN1 | 6.0% Decrease Gene Expression Level | |
DAA49 | colony stimulating factor 2 (granulocyte-macrophage) | Molecular | brain | Human | CSF2 | 6.0% Increase Gene Expression Level | |
DAA17 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | Molecular | brain | Human | ATP5A1 | 17.0% Decrease Gene Expression Level | |
DAA11 | annexin A4 | Molecular | brain | Human | ANXA4 | 11.0% Increase Gene Expression Level | |
DAA18 | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Molecular | brain | Human | ATP5B | 9.0% Decrease Gene Expression Level | |
DAA2 | abl-interactor 2 | Molecular | brain | Human | ABI2 | 18.0% Decrease Gene Expression Level | |
DAA8 | angiomotin | Molecular | brain | Human | AMOT | 10.0% Increase Gene Expression Level | |
DAA40 | cholecystokinin B receptor | Molecular | brain | Human | CCKBR | 11.0% Decrease Gene Expression Level | |
DAA24 | B-cell CLL/lymphoma 11A (zinc finger protein) | Molecular | brain | Human | BCL11A | 14.0% Decrease Gene Expression Level | |
DAA9 | ankyrin 2, neuronal | Molecular | brain | Human | ANK2 | 20.0% Decrease Gene Expression Level | |
DAA45 | Cdc2-related kinase, arginine/serine-rich | Molecular | brain | Human | CDK12 | 17.0% Increase Gene Expression Level | |
DAA47 | crystallin, beta B3 | Molecular | brain | Human | CRYBB3 | 4.0% Decrease Gene Expression Level | |
DAA48 | crystallin, mu | Molecular | brain | Human | CRYM | 12.0% Decrease Gene Expression Level |